Inhibitors of histone deacetylase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE49240
SERIAL NO

16815755

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds which inhibit histone deacetylase activity and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing these compounds. The present invention also relates to methods of treating and preventing hematological cell proliferative disorders, such as multiple myeloma, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE GENERAL HOSPITAL CORPORATIONBOSTON MA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, Kenneth C Wellesley, US 56 416
Ghosh, Balaram Hyderabad, IN 13 24
Haggarty, Stephen J Gloucester, US 39 456
Hideshima, Teru Brookline, US 20 228
Mazitschek, Ralph Belmont, US 92 1078

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 11, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 11, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 11, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00